businesspress24.com - SpectraScience to Present at Rodman & Renshaw's 13th Annual Healthcare Investment Conferenc
 

SpectraScience to Present at Rodman & Renshaw's 13th Annual Healthcare Investment Conference

ID: 1037036

(firmenpresse) - SAN DIEGO, CA -- (Marketwire) -- 09/06/11 -- SpectraScience, Inc. (OTCQB: SCIE), a San Diego based medical device company, today announced it will participate in Rodman & Renshaw Annual Global Investment Conference. The Company is scheduled to present in the North Foyer at the Waldorf-Astoria Hotel in New York City from 4:55pm to 5:20pm on Tuesday, September 13th.

During the conference, management will be available to meet with analysts, portfolio managers and investors. Interested parties who wish to meet with SpectraScience's management may contact Rodman & Renshaw directly. Participation in the conference is by invitation only.

Michael Oliver, CEO of SpectraScience, said that, "The Rodman & Renshaw Conference is a great opportunity for the Company to showcase its upcoming WavSTAT 4 Optical Biopsy System introduction and future prospects in the medical device sector and to further our efforts to gain additional exposure. With more than 4,000 attendees (including private equity funds, institutional investors, sophisticated private investors and company executives), the Rodman & Renshaw Conference will provide the Company with new opportunities to attract new and greater interest in our efforts toward building a leading medical device technologies company."

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.



Contact:
SpectraScience, Inc.
Jim Dorst
Chief Financial Officer




(858) 405-9933


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Insight Into Market Ahead - Equity Research on Liquidity Services, Inc. and Amazon.com, Inc.
Factors Moving Markets, Worldwide View - Equity Research on Ciena Corporation and Alcatel-Lucent
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 06.09.2011 - 07:00 Uhr
Sprache: Deutsch
News-ID 1037036
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

SAN DIEGO, CA


Phone:

Kategorie:

Commercial & Investment Banking


Anmerkungen:


Diese Pressemitteilung wurde bisher 92 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"SpectraScience to Present at Rodman & Renshaw's 13th Annual Healthcare Investment Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von

SpectraScience, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von SpectraScience, Inc.



 

Who is online

All members: 10 568
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 91


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.